Keywords
How to Cite
Abstract
The literature and our own experience were analyzed in multimodal approach to the treatment of patients with malignant pleural mesothelioma (MPM). Survival and quality of life of patients with MPM who underwent multimodal treatment, according to modern standards, are often limited by the occurrence of local recurrences. The value of a number of local therapy methods is still being explored in order to determine the possible side effects as well as the duration of disease-free survival. Photodynamic therapy and intraoperative hyperthermic chemoperfusion of the pleural cavity are the methods of the local treatment of this disease, applied after surgery. These approaches have been investigated separately in several studies, but their efficacy and tolerability is still not clear. The authors wanted to find the best indications for the use of these methods and to assess the immediate and long-term results.References
Мерабишвили В.М. Онкологическая служба Санкт-Петербурга (оперативная отчётность за 2010г., углублённая разработка базы данных регистра по международным стандартам) Ежегодник популяционного ракового регистра № 17 СПб.: Коста, 2011. - С. 334.
Музалевский П.Н., Шойхет Я.Н., Лазарев А.Ф., Григорук О.Г. Мезотелиома: распространённость и модифицирующие факторы (Литературный обзор) // Сиб. Онкол. журнал. - 2007. - № 2. - С. 77-83.
Ambrogi V., Baldi A., Schillaci O. et al. Clinical impact of extrapleural pneumonectomy for malignant pleural mesothelioma // Ann. Surg. Oncol. - 2012. - Vol. 19. - P. 1692-1699.
Baldini E.H., Recht A., Strauss G.M. et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma // Ann. Thorac. Surg. - 1997. - Vol. 63 (2). - P. 334-338.
Batirel H.F., Metintas M., Caglar H.B. et al. Trimodality treatment of malignant pleural mesothelioma // J. Thorac. Oncol. - 2008. - Vol. 3. - P. 499-504.
Buduhan G., Menon S., Aye R. et al. Trimodality therapy for malignant pleural mesothelioma // Ann. Thorac. Surg. - 2009. - Vol. 88. - P. 870-875; discussion 876.
Flores R.M., Pass H.I., Seshan V.E. et al. Extrapleural-pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients // J. Thorac. Cardiovasc. Surg. - 2008. - Vol. 135 (3). - P. 620-626.
Krug L.M., Pass H.I., Rusch V.W. et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma // J. ClinOncol. - Vol. 2009. - Vol. 27. - P. 3007-3013.
Lang-Lazdunski L., Bille A., Lal R. et al. Pleurectomy/ decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma // J. Thorac. Oncol. - 2012. - Vol. 7. - P. 737-743.
Larson T., Melnikova N., Davis S.I. et al. Incidence and descriptive epidemiology of mesothelioma in the United States, 1999-2002 // Int. J. Occup. Environ. Health. - 2007. - Vol. 13. - P. 398-403.
Luckraz H., Rahman M., Patel N. et al. Three decades of experience in the surgical multi-modality management of pleural mesothelioma // Eur J. Cardiothorac. Surg. 2010. - Vol. 37. - P. 552-556.
Merritt N., Blewett C.J., Miller J.D. et al. Survival after conservative (palliative) management of pleural malignant mesothelioma // J. Surg. Oncol. - 2001. - Vol. 78 (3). - P. 171-174.
Milano M.T., Zhang H. Malignant pleural mesothelioma: a population-based study of survival // J. Thorac. Oncol. - 2010. - Vol. 5 (11). - P. 1841-1848.
Pagan V., Ceron L., Paccagnella A. et al. 5-year prospective results of trimodality treatment for malignant pleural mesothelioma // J. CardiovascSurg (Torino). - 2006. - Vol. 47. - P. 595-601.
Patel P.R., Yoo S., Broadwater G. et al. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy // Int J. Radiat Oncol Biol Phys. - 2012. - Vol. 83. - P. 362-368.
de Perrot M., Feld R., Cho B.C. et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma // J. ClinOncol. - 2009. - Vol. 27. - P. 1413-1418.
Price B., Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005 // Crit. Rev. Toxicol. - 2009. - Vol. 39. - P. 576-588.
Rea F., Marulli G., Bortolotti L. et al. Induction chemotherapy, extrapleuralpneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results // Lung Cancer 2007. - Vol. 57. - P. 89-95.
Rena O., Casadio C. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure // Lung Cancer. - 2012. - Vol. 77. - P. 151-155.
Van Schil P.E., Baas P., Gaafar R. et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial // Eur. Respir. J. - 2010. - Vol. 36. - P. 1362-1369.
Sugarbaker D.J., Flores R.M., Jaklitsch M.T. et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodalitytherapy of malignant pleural mesothelioma: results in 183 patients // J. Thorac. Cardiovasc. Surg. - 1999. - Vol. 117. - P. 54-63; discussion 63-65.
Tonoli S., Vitali P., Scotti V. et al. Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series // Radiother. Oncol. - 2011. - Vol. 101. - P. 311-315.
Treasure T., Lang-Lazdunski L., Waller D. et al. Extrapleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study // Lancet Oncol. - 2011. - Vol. 12. - P. 763-772.
Weder W., Stahel R.A., Bernhard J. et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma // Ann Oncol. - 2007. - Vol. 18. - P. 1196-1202.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...